Chimeric Therapeutics Ltd Cash Flow Quality Index

Latest as of December 2023: -3.81x

Chimeric Therapeutics Ltd cash flow quality index. Chimeric Therapeutics Ltd (CHM) has a Cash Flow Quality Index of -3.81x as of December 2023. Operating cash flow of AU$-4.66 Million is below net income of AU$1.22 Million, suggesting accrual-heavy earnings not yet converted to cash. See Chimeric Therapeutics Ltd (CHM) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-3.81x

Operating CF / Net Income

Operating Cash Flow

AU$-4.66 Million

AUD

Net Income

AU$1.22 Million

AUD

Data as of

Dec 2023

Most recent filing

Chimeric Therapeutics Ltd Cash Flow Quality Index by Year (None–None)

Chimeric Therapeutics Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Chimeric Therapeutics Ltd. For the full cash flow conversion analysis, see CHM operating cash flow.

Year	Quality Index	Operating CF (AUD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.